Small Scale Bioreactors Market is Estimated To Witness High Growth Owing To Increased Adoption of Continuous Manufacturing Processes

Poonam

Small Scale Bioreactors Market is Estimated To Witness High Growth Owing To Increased Adoption of Continuous Manufacturing Processes

The Small Scale Bioreactors Market is estimated to be valued at US$ 1508.86 Mn in 2023 and is expected to exhibit a CAGR of 10.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Small scale bioreactors are benchtop bioreactors used for cell culture process development and production of therapeutics. Small scale bioreactors are adopted for small production batches ranging from 1 L to 100 L and are suitable for R&D activities. These bioreactors incorporate various process parameters such as pH, temperature, agitation, and oxygenation, to closely mimic large industrial bioreactor processes.

Market key trends:

Increased adoption of continuous manufacturing processes: Continuous manufacturing using small scale bioreactors is gaining increased adoption in biopharmaceutical production as it offers higher flexibility, improved process control, and reduced waste generation compared to batch processes. Continuous bioprocessing enables 24/7 production, reduced contamination risks, and smaller facility footprints.

High demand for personalized and niche biologics: Growing demand for personalized medicine and orphan drugs is driving increased R&D activities involving small-scale bioreactors. Development of niche biologics requires flexible and customizable bioprocessing solutions which small-scale bioreactors provide. Their suitability for low volume production makes them ideal for developing personalized biologics.

Porter's Analysis

Threat of new entrants: The high R&D costs and capital requirements to operate in this market pose significant barriers for new entrants.

Bargaining power of buyers: Buyers have moderate bargaining power due to the presence of a large number of established vendors providing small scale bioreactors.

Bargaining power of suppliers: Suppliers have low to moderate bargaining power due to the availability of alternative component suppliers in the market.

Threat of new substitutes: Low threat as small scale bioreactors provide specific advantages over large scale bioreactors.

Competitive rivalry: High due to the presence of many global and regional vendors competing on product features and pricing.

SWOT Analysis

Strength: Ability to provide flexible and customizable small-scale bioprocesses. Wide applications in research, process & product development.

Weakness: High initial investment and operational costs. Require specialized skills to operate.

Opportunity: Growing biopharmaceutical industry driving demand. Adoption in academic research and gene therapy.

Threats: Stringent regulatory guidelines. Competition from large scale bioreactors.

Key Takeaways

The global Small Scale Bioreactors Market Growth is expected to witness high growth at a CAGR of 10% over the forecast period due to increasing demand for personalized medicine and cell & gene therapies.

Regionally, North America is expected to dominate the market during the forecast period owing to rising biotechnology research and presence of major vendors in the US. Asia Pacific is anticipated to exhibit the fastest growth rate due to improving healthcare infrastructure and increasing outsourcing of clinical trials to countries like China and India.

Key players operating in the small scale bioreactors market are Merck KGaA, Danaher Corporation, Getinge AB, Sartorius AG, Thermo Fisher Scientific Inc., Lonza Group, Eppendorf AG, Miltenyi Biotec, Solaris Biotechnology Srl, Infors AG, Biosan, MicroDigital Co. Ltd., 2mag AG, MDX Biotechnik International GmbH, Esco Lifesciences Group, HiTec Zang GmbH, Hanil Scientific Inc., Adolf Kühner AG, Ori Biotech, Aglaris and AdvaBio. Major players are focusing on new product launches and expansions to strengthen their market position.

Poonam

Small Scale Bioreactors Market: Growing Demand for Biopharmaceuticals Drives Market Growth

Sneha 2023-10-19

The global Small Scale Bioreactors Market is estimated to be valued at US$ 1,233. The need for small-scale bioreactors is increasing, driven by the growing demand for biopharmaceuticals and advancements in biotechnology research. Porter’s Analysis:-· Threat of New Entrants: The threat of new entrants in the small-scale bioreactors market is relatively low. In terms of regional analysis, North America is the fastest growing and dominating region in the small-scale bioreactors market. In conclusion, the small-scale bioreactors market is expected to grow significantly over the forecast period, driven by the adoption of single-use bioreactors and the increasing demand for personalized medicine.

Small Scale Bioreactors Market is driven by increased demand for monoclonal antibodies

Purvaja 2023-12-20

The global Small Scale Bioreactors Market is estimated to be valued at US$ 1508. With growing monoclonal antibody therapeutics market, demand for small scale bioreactors is also expected to rise in coming years to support research and development activities. Threat of new substitutes: Low as bioreactors have limited substitutes for certain applications like monoclonal antibody production, cell culture production. Key Takeaways The global Small Scale Bioreactors Market Demand is expected to witness high growth over the forecast period. The global Small Scale Bioreactors Market is estimated to be valued at US$ 1508. Key players operating in the small scale bioreactors market are Merck KGaA ,Danaher Corporation, Getinge AB, Sartorius AG ,Thermo Fisher Scientific Inc.

Small Scale Bioreactors Market Growth Accelerated By Adoption Of Single-Use Systems

Dhanesha Patil 2024-02-12

The major advantages of small scale bioreactors include less media requirement, flexibility in cell culture processes, and ease of scale-up. They help in reducing the risk and cost involved in large scale manufacturing by allowing optimization at small scale. The global Small Scale Bioreactors Market is estimated to be valued at US$ 117. The growth of contract manufacturing organizations and biopharmaceutical companies focusing on small batch manufacturing has substantially driven the adoption of single-use small scale bioreactors. Segment Analysis The Global Small Scale Bioreactors Market Demand is dominated by benchtop bioreactors sub-segment due to their small size and easy handling nature.

The Rise Of Small Scale Bioreactors Revolutionizing Bioprocessing

Rahul Kumar Yadav 2023-06-30

The rise of Small Scale Bioreactors is revolutionizing the field of bioprocessing, offering significant advancements and opportunities in various industries such as pharmaceuticals, biotechnology, and biofuels. Traditionally, large-scale bioreactors have been the go-to choice for industrial bioprocessing. One of the key advantages of Small Scale Bioreactors is their scalability. Moreover, small-scale bioreactors require smaller volumes of culture media and have shorter turnaround times, leading to reduced costs and faster process development. The rise of small-scale bioreactors has democratized bioprocessing, making it accessible to a broader range of industries, research institutions, and even individual scientists.

Small-Scale LNG Market Will Witness Substantial Growth in the Upcoming years by 2027

Data Bridge Market Research 2021-11-17

In this era of globalization, many businesses call for Global Market Research to support decision making. This global market report additionally encompasses predictions utilizing a practical arrangement of suspicions and techniques. Top Key Players of this Global Small-Scale LNG Market –Linde, Sofregaz Company, WÄRTSILÄ, Stabilis Energy, Inc. com/reports/global-small-scale-lng-marketRegional market analysis Global Small-Scale LNG can be represented as follows:Each regional Small-Scale LNG for Rigid Foams sectors is carefully studied to understand its current and future growth scenarios. About Us:Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches.

Small-Scale LNG Market is Expected to Surpass US$ 2.6 Billion by 2025| MarketsandMarkets™

marketsandmarkets 2022-11-08

The global small-scale LNG market size is projected to reach USD 2. id=226707057 Based on type, the liquefaction segment is projected to account for the larger share in terms of value during the forecast period. The factors mentioned above will drive demand for small-scale LNG during the forecast period. However, factors such as the global economic slowdown and limited receiving terminal infrastructure in APAC could affect market growth. (US), General Electric (US), Engie (France), and Gazprom (Russia) are some of the key players dealing in small-scale LNG globally.

WHO TO FOLLOW